• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » sBioMed taps ex-Stryker CEO MacMillan as CEO

sBioMed taps ex-Stryker CEO MacMillan as CEO

November 1, 2012 By Brad Perriello

sBioMed CEO Stephen MacMillan

Former Stryker (NYSE:SYK) CEO Stephen MacMillan, whose sudden ouster from the medical device company earlier this year shocked medtech, tells MassDevice.com that he has a new gig: CEO and part-owner of sBioMed, which makes an anti-infection agent called Steriplex SD.

We spoke with a relaxed-sounding MacMillan last week from his new base in Orem, Utah, where SBioMed has its headquarters. In a wide-ranging chat, he told us about the wrenching separation from Stryker, how he adjusted to "civilian life" and what’s behind his latest move.

Sign up to get our free newsletters delivered right to your inbox

The impetus to join sBioMed came from a desire to find a business opportunity that would have a meaningful impact on healthcare, MacMillan told us. Eight-year-old sBioMed says the Steriplex SD solution kills clostridium difficile, a healthcare-associated infection that’s named for its notorious hardiness. Citing "user-friendly chemistries," the company says its "non-fuming and non-corrosive" formula is a green alternative to bleach.

"After a decade of research, over 500 studies and EPA registration, we are excited to enter the full-scale commercialization process. With Steve’s leadership, we can help eliminate healthcare-associated infections globally," sBioMed co-founder and chairman Brian Larson said in prepared remarks.

MacMillan told us that the potential market for the product goes far beyond the multi-billion-dollar hospital market.

"There are also enormous opportunities for this product in the animal health world, in the hospitality world, restaurants, hotels, big in the agriculture world, pharmaceutical clean rooms. There are a whole bunch of markets beyond just the core hospital market," he said. "Ultimately I think there is a big consumer angle. What I see is the chance to build a major significant company that is doing some good for the world."

MacMillan declined to specify just how large a stake he acquired in sBioMed, saying only that it was "significant" and "meaningful."

MacMillan resigned from Stryker Feb. 8, citing family reasons, sending shock waves throughout the medical device world. Rumors soon surfaced that his ouster was due to board members’ consternation over his relationship with an ex-employee; it later emerged that MacMillan had sought the board’s approval after his divorce was final and before he began the relationship.

Asked about his very public departure and the attention to his personal life, MacMillan termed his ouster "unfair."

"There are a lot of great people at Stryker. I think my exit was an unfortunate and unfair experience. To me it was unfair, unfortunate and personally challenging," he told us. "My exit was not precipitated by any unethical or poor behavior. Yet it appeared that way, and that was very difficult to deal with, for both me and my family."

Relations with the board were touchy at the outset, as MacMillan was relatively young to helm a major public company (he was named president & COO at 39 and took over the corner office at 41). He was also replacing John Brown, whom MacMillan called "a legend," after 3 decades as CEO.

"As a younger, hard-charging person dramatically changing a company, to adjust it to the new realities, you build some scar tissue with board members," he explained. "We then had to go through a lot of significant changes, the regulatory environment change, we had to move away from delivering 20% earnings growth. We had to make some changes to some of the board structures.

"Then when you start to change over the board and ask a few long-serving people to step down, bring some new ones on, it can create some very difficult dynamics in the boardroom. I think I built up some scar tissue and there became a convenient reason for some members of the board to lose some confidence in me. That just is not a fun environment to operate in."

That said, MacMillan seemed relaxed and energized by his new situation in Utah and fond of his time at Stryker, despite its ugly end.

"I am remarkably proud of what we accomplished at Stryker. During the years I was there, we tripled the revenues, we diversified the business, we dramatically enhanced the quality in manufacturing operations. That’s a real testimony to the strength of the employee base. That’s not the result of any 1 person, but I am very proud of so much of what we did there, still very proud of the employees and company."

Filed Under: News Well Tagged With: Medical Supplies, Personnel Moves, sBioMed, Stryker

In case you missed it

  • They said it at DeviceTalks Boston
  • Elucid raises $27M for heart disease diagnosis software
  • Summer health technology program brings diverse group of interns to Silicon Valley
  • BioSig expects to raise $3.5M from public offering
  • Haemonetics completes move to new Pennsylvania manufacturing facility
  • Vivera adds two industry veterans to its technology advisory board
  • Abbott Fund grants $750k to education, health equity program
  • Another Medtronic HVAD recall is serious
  • Endologix reports positive results from percutaneous bypass trial
  • NorthStar Medical names new president and chief operating officer
  • Vektor Medical names Rob Krummen as CEO
  • Baxter’s Volara lung therapy system recall is Class I
  • BD voluntarily recalls intraosseous products
  • Bioventus restructures $315M CartiHeal acquisition
  • Intrommune extends scope of Phase 1 trial for peanut-allergy-treating toothpaste
  • How SeaStar’s device calms hyperinflammation — and could prevent lasting damage from COVID cytokine storms
  • Hamilton Medical warns on some ventilators

RSS From Medical Design & Outsourcing

  • They said it at DeviceTalks Boston
    Medtech insiders convened at DeviceTalks Boston 2022 in May to discuss device design, innovation and trends shaping the industry now and in the years and decades ahead. Here are some of the most quotable insights from panelists and speakers at our live event. And make sure to save the date — and save your seat… […]
  • Summer health technology program brings diverse group of interns to Silicon Valley
    Diversity by Doing HealthTech (DxD) is holding a Summer Innovation and Exploration Series for college student interns from underrepresented groups. The series is on its second day today at Fogarty Innovation and Stanford Byers Center for Biodesign — the two organizations that jointly formed and support DxD. The event debuted last year in an online… […]
  • Clippard releases new series of isolation valves
    Clippard (Cincinnati) has Its Clippard NIV Series media isolation valve — a solenoid-operated device using a flexible diaphragm to isolate the actuation mechanism from the fluid path. Media isolation valves find everyday use in a wide variety of applications. Think uses that require precise, repeatable dispensing of media for analytical instrumentation. Clippard says media isolation… […]
  • Another Medtronic HVAD recall is serious
    A year after Medtronic ceded the LVAD market to Abbott, it has yet another Class I recall involving HeartWare Ventricular Assist Device pumps still implanted in patients. The FDA today designated a Medtronic recall involving the HVADs as Class I, the most serious level. It’s the second Class I recall designation for the HVADs this… […]
  • How SeaStar’s device calms hyperinflammation — and could prevent lasting damage from COVID cytokine storms
    SeaStar Medical recently won FDA breakthrough device designation for a new way to treat hyperinflammation with technology that could help fight chronic conditions from COVID-19 infections. The Denver-based medical developer is seeking a humanitarian device exemption for treating children with acute kidney injury (AKI) based on an FDA-funded study, SeaStar President and CEO Eric Schlorff… […]
  • How Avail Medsystems seeks to create a connected OR experience
    Much like a normal Starbucks-goer expects the coffee to taste a certain way at any location, Daniel Hawkins wants that type of experience in the operating room. Hawkins is the CEO of Avail Medsystems, a company developing telemedicine equipment that can connect surgeons, interventional specialists and medical device sales reps. Hawkins and the team at Avail… […]
  • How to leverage technology to drive diversity in clinical studies
    Convenience was the driver, and the traditional clinical trial model had to evolve when it came to a colorectal cancer screening study. The clinical study had 35,000 patients across the U.S. Chuanbo Xu, Freenome Cancer doesn’t discriminate. It’s the second-leading cause of death in the U.S. Early detection is key in treating — and even… […]
  • Medical device licensing pitfalls to avoid
    Prevent costly disputes caused by these common mistakes in patent license agreements. Marcelo Barros, Kathleen Daley, Brian Kacedon and Matthew Ritter, Finnegan Licensing and other technology transfer agreements can be critical for medical device companies that invest significantly into new technology R&D and seek and obtain intellectual property protection for those investments. But if these agreements… […]
  • Tolerance stack-up: Insight into the inner workings of high-density microelectronic medical devices
    Tolerance stack-up is a defining design concept to ensure new products are built efficiently and effectively.  Darren Gilmer, Intricon At a time when the future of micro-miniature medical devices seems unlimited, one fundamental reality remains firmly in place — the sizes and shapes of human anatomy. From blood vessels to ear canals, respiratory passages to… […]
  • Deburring and finishing for beautiful, functional medical devices
    The latest automated cutting tools help medical device manufacturers meet strict specs and high demand. Dave Sawicki, Xebec Increasing demand and advances in technology are driving growth in the medical device industry. Chronic diseases are more prevalent, and the aging population is larger, contributing to the demand for highly regulated Class III medical devices such… […]
  • FDA seeking innovations to move beyond heater-cooler device problems
    The FDA issued a notice today saying that it is working to evaluate new strategies to mitigate infections associated with heater-cooler devices. According to the notice, the administration is collaborating with professional societies, public health partners, heater-cooler manufacturers, and experts on the matter surrounding the heater-cooler devices used during medical and surgical procedures to warm… […]

Leave a Reply

You must be logged in to post a comment.

Primary Sidebar

DeviceTalks Weekly

June 24, 2022
How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS